Cargando…

Cellular bioenergetics is impaired in patients with chronic fatigue syndrome

Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomas, Cara, Brown, Audrey, Strassheim, Victoria, Elson, Joanna, Newton, Julia, Manning, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655451/
https://www.ncbi.nlm.nih.gov/pubmed/29065167
http://dx.doi.org/10.1371/journal.pone.0186802
_version_ 1783273538135785472
author Tomas, Cara
Brown, Audrey
Strassheim, Victoria
Elson, Joanna
Newton, Julia
Manning, Philip
author_facet Tomas, Cara
Brown, Audrey
Strassheim, Victoria
Elson, Joanna
Newton, Julia
Manning, Philip
author_sort Tomas, Cara
collection PubMed
description Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were conducted using peripheral blood mononuclear cells (PBMCs) from CFS patients and healthy controls. These experiments investigated cellular patterns in oxidative phosphorylation (OXPHOS) and glycolysis. Results showed consistently lower measures of OXPHOS parameters in PBMCs taken from CFS patients compared with healthy controls. Seven key parameters of OXPHOS were calculated: basal respiration, ATP production, proton leak, maximal respiration, reserve capacity, non-mitochondrial respiration, and coupling efficiency. While many of the parameters differed between the CFS and control cohorts, maximal respiration was determined to be the key parameter in mitochondrial function to differ between CFS and control PBMCs due to the consistency of its impairment in CFS patients found throughout the study (p≤0.003). The lower maximal respiration in CFS PBMCs suggests that when the cells experience physiological stress they are less able to elevate their respiration rate to compensate for the increase in stress and are unable to fulfil cellular energy demands. The metabolic differences discovered highlight the inability of CFS patient PBMCs to fulfil cellular energetic demands both under basal conditions and when mitochondria are stressed during periods of high metabolic demand.
format Online
Article
Text
id pubmed-5655451
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56554512017-11-09 Cellular bioenergetics is impaired in patients with chronic fatigue syndrome Tomas, Cara Brown, Audrey Strassheim, Victoria Elson, Joanna Newton, Julia Manning, Philip PLoS One Research Article Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were conducted using peripheral blood mononuclear cells (PBMCs) from CFS patients and healthy controls. These experiments investigated cellular patterns in oxidative phosphorylation (OXPHOS) and glycolysis. Results showed consistently lower measures of OXPHOS parameters in PBMCs taken from CFS patients compared with healthy controls. Seven key parameters of OXPHOS were calculated: basal respiration, ATP production, proton leak, maximal respiration, reserve capacity, non-mitochondrial respiration, and coupling efficiency. While many of the parameters differed between the CFS and control cohorts, maximal respiration was determined to be the key parameter in mitochondrial function to differ between CFS and control PBMCs due to the consistency of its impairment in CFS patients found throughout the study (p≤0.003). The lower maximal respiration in CFS PBMCs suggests that when the cells experience physiological stress they are less able to elevate their respiration rate to compensate for the increase in stress and are unable to fulfil cellular energy demands. The metabolic differences discovered highlight the inability of CFS patient PBMCs to fulfil cellular energetic demands both under basal conditions and when mitochondria are stressed during periods of high metabolic demand. Public Library of Science 2017-10-24 /pmc/articles/PMC5655451/ /pubmed/29065167 http://dx.doi.org/10.1371/journal.pone.0186802 Text en © 2017 Tomas et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tomas, Cara
Brown, Audrey
Strassheim, Victoria
Elson, Joanna
Newton, Julia
Manning, Philip
Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title_full Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title_fullStr Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title_full_unstemmed Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title_short Cellular bioenergetics is impaired in patients with chronic fatigue syndrome
title_sort cellular bioenergetics is impaired in patients with chronic fatigue syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655451/
https://www.ncbi.nlm.nih.gov/pubmed/29065167
http://dx.doi.org/10.1371/journal.pone.0186802
work_keys_str_mv AT tomascara cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome
AT brownaudrey cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome
AT strassheimvictoria cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome
AT elsonjoanna cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome
AT newtonjulia cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome
AT manningphilip cellularbioenergeticsisimpairedinpatientswithchronicfatiguesyndrome